European regulatory conundrum of phage therapy

Gilbert Verbeken??, Daniel De Vos??^?, Mario Vaneechoutte??, Maya Merabishvili??, Martin Zizi?? & Jean-Paul Pirnay?? ??Author for correspondence

The treatment of infectious diseases with antibiotics is becoming increasingly challenging. Very few new antimicrobials are in the pharmaceutical industry pipeline. One of the potential alternatives for antibiotics is phage therapy. Major obstacles for the clinical application of bacteriophages are a false perception of viruses as ‘enemies of life’ and the lack of a specific frame for phage therapy in the current Medicinal Product Regulation. Short-term borderline solutions under the responsibility of a Medical Ethical Committee and/or under the umbrella of the Declaration of Helsinki are emerging. As a long-term solution, however, we suggest the creation of a specific section for phage therapy under the Advanced Therapy Medicinal Product Regulation.

Full Text PDF (1084 KB) PDF Plus (1094 KB)

Cited by

Damien Maura, Laurent Debarbieux??. (2011) Bacteriophages as twenty-first century antibacterial tools for food and medicine. Applied Microbiology and Biotechnology
Online publication date: 29-Mar-2011.
CrossRef Jenny Fernebro??. (2011) Fighting bacterial infections—Future treatment options. Drug Resistance Updates
Online publication date: 1-Mar-2011.
CrossRef Jean-Paul Pirnay, Daniel Vos, Gilbert Verbeken, Maia Merabishvili, Nina Chanishvili, Mario Vaneechoutte, Martin Zizi, Geert Laire, Rob Lavigne, Isabelle Huys, Guy Mooter, Angus Buckling, Laurent Debarbieux, Flavie Pouillot, Joana Azeredo, Elisabeth Kutter, Alain Dublanchet, Andrzej Górski, Revaz Adamia??. (2010) The Phage Therapy Paradigm: Prêt-à-Porter or Sur-mesure?. Pharmaceutical Research
Online publication date: 10-Nov-2010.
CrossRef Pieter-Jan Ceyssens??, Rob Lavigne??. (2010) Bacteriophages of Pseudomonas. Future Microbiology 5:7, 1041-1055
Online publication date: 1-Jul-2010.
Summary | Full Text | PDF (2216 KB) | PDF Plus (2283 KB)  | Reprints & Permissions T. Glonti, N. Chanishvili, P.W. Taylor??. (2010) Bacteriophage-derived enzyme that depolymerizes the alginic acid capsule associated with cystic fibrosis isolates of Pseudomonas aeruginosa. Journal of Applied Microbiology 108:2, 695-702
Online publication date: 1-Feb-2010.
CrossRef Jean-Paul Pirnay, Daniel Vos, Gilbert Verbeken, Maia Merabishvili, Nina Chanishvili, Mario Vaneechoutte, Martin Zizi, Geert Laire, Rob Lavigne, Isabelle Huys??. (2010) The Phage Therapy Paradigm: Prêt-à-Porter or Sur-mesure?. Pharmaceutical Research
CrossRef Ryszard Mi?dzybrodzki, Wojciech Fortuna, Beata Weber-D?browska, Andrzej Górski??. (2009) A retrospective analysis of changes in inflammatory markers in patients treated with bacterial viruses. Clinical and Experimental Medicine 9:4, 303-312
Online publication date: 1-Dec-2009.
CrossRef Kwang-Pyo Kim, Jeong-Dan Cha, Eun-Hye Jang, Jochen Klumpp, Steven Hagens, Wolf-Dietrich Hardt, Kyung-Yeol Lee, Martin J. Loessner??. (2008) PEGylation of bacteriophages increases blood circulation time and reduces T-helper type 1 immune response. Microbial Biotechnology 1:3, 247-257
Online publication date: 1-May-2008.
CrossRef